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SUM MARY
The titration curves of the human hemoglobins A 2 and
F, the slow and fast components of horse hemoglobin, and 
bovine hemoglobin B have been analyzed, mainly to obtain 
information about the titration behavior of the histidines in 
these hemoglobins. The results were also compared with 
earlier data concerning human hemoglobin A and bovine 
hemoglobin A.
In both hemoglobin A 2 and F, 18 titratable histidines were 
found, two less than in hemoglobin A. Assuming that those 
histidyl residues which in the three-dimensional model 
occupy the sam e sites will show similar titration behavior, we 
reached the conclusion that in human hemoglobin histidine 
G19 and histidine H21 are titratable and that histidine G18 is 
not titratable.
Both the slow and fast components of horse hemoglobin 
were found to contain 22 titratable histidines and 70 titratable 
carboxyl groups. Combining these results with th e  known 
number of amides in the a  chain w e calculated that the 
/3 chain should contain 11 am ides.
It appeared that in bovine hemoglobin B the histidines at 
Bl(18)/3, which are absent in bovine hemoglobin A, are 
titratable. The pK of these histidines, as estimated from 
the difference titration curve, is about 7.8, both in oxy- and 
deoxyhemoglobin. This high pK is probably caused by the 
formation of a saltbridge with the carboxyl group of aspartic 
acid B3(20)ö in the sam e chain. Both hemoglobins contain 
72 titratable carboxyl groups.
Comparing the human, horse, and bovine hemoglobins, 
assuming again similar titration behavior for structurally 
identical histidines, w e were able to correlate the titration 
results of human and horse hemoglobin. The human and 
bovine hemoglobins failed to show an equally good correla- 
tion, although the discrepancy was small.
It has been established by Steinhardt and Zaiser (1), Stein- 
hardt and Hiremath (2), and Geddes and Steinhardt (3) that at 
acid pH groups are becoming titratable in hemoglobin which are 
masked when the protein is in  its native state. In the case of 
horse carboxyhemoglobin it was found (3) that out of a  total of
24 groups liberated, a t least 12 were imidazole groups. An 
estimation of the number of groups unmasked at acid pH is 
comphcated by the fact that the electrostatic interaction Factor 
w changes simultaneously with unmasking. Therefore to find 
the number of titratable histidines in hemoglobin we have fol- 
lowed a different approach which consists of a direct mcasurc - 
ment or counting of the total number of histidines whieh are 
titrated in the neutral pH  region where the protein is in  its na­
tive state. A direct counting procedure, although different from 
ours, was also followed by Tanford and Nozaki (4) for human 
and horse hemoglobin and by Bucci et al. (5) for human hemo­
globin and its subunits. The accuracy of their analyzing pro­
cedure was about one-half histidine per heme or two groups per 
tetramer. In earlier reports on bovine and human hemoglobin 
(6, 7) we have introduced a measuring and analyzing procedure 
for titration curves which permits a greater accuracy in the de­
termination of the number of titratable histidines. In  this paper 
we have extended our study to human hemoglobins A2 and F, 
horse hemoglobin, including the slow and fast components, and 
bovine hemoglobin B.
In our analyses of the several hemoglobins we also present an 
efiort to  correlate the data of the several hemoglobins in order 
to get information about the titratability and pK values of par- 
ticular histidines.
e x p e r im e n t a l  p r o c e d u r e
Hemoglobin solutions were prepared following the toluene 
method of Drabkin (8).
The two components of horse hemoglobin were isolated as de­
scribed by  Perutz et al. (9). B y this method the so-called slow 
and fast components are obtained as methemoglobin. The two 
fractions were concentrated by means of a Diaflo ultrafiltration 
cell and subsequently converted to the cyanomet derivatives. 
The separation was checked with polyacrylamide gel electro- 
phoresis at pH 8.
T he method of Bem ini (10) for the isolation of human hemo­
globin A 2 was somewhat modified in order to obtain larger quan- 
tities. As buffers were used 0.2 m Tris to which 0.2 m N aH 2PC>4 
was added until the pH  was 8.5, and a solution of 0.035 m Tris 
adjusted to pH  8.5 w ith 0.035 M N aH 2PC>4. Chromatography 
was performed on DEAE-Sephadex type A-50. Ten grams of 
this resin were allo wed to swell in the first buffer for 12 hours and 
subsequently washed several times with the second buffer. Be- 
fore operating the column (4 X 20 cm) was equilibrated with
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the second buffer. The column was charged with 40 ml of a 
hemoglobin solution, concentration about 100 g per liter, pre- 
viously dialyzed against the second buffer. Subsequently the  
column was eluted with this buffer. The hemoglobin A2 moved 
rapidly through the column and could satisfactorily be separated 
from the main component. The solution containing hemoglobin 
A2 was concentrated by means of ultrafiltration and dialyzed  
against distilled water. The separation was checked by  poly- 
acrylamide gel electrophoresis a t pH  8. The whole procedure 
was carried out at 4°. To one sample of hemoglobin A2, N a2S20.i 
was added and the solution im mediately deionized (11) in order 
to reduce ariy methemoglobin which m ight have been formed 
during the whole procedure. The titration curve obtained  
from this sample was not significantly different from that of an 
untreated sample.
Bovine hemoglobin B was obtained from a B B  genotype of the 
Limousine breed.
Hemoglobin isolated from umbilical cord blood was used for 
the hemoglobin F  studies. The amount of hemoglobin F  was 
determined by  the alkali denaturation test (12).
Before titration all hemoglobin solutions were dialyzed against 
distilled water and subsequently deionized by repeated passing 
through a mixed bed ion exchange column.
The concentrations of the hemoglobin solutions were deter­
mined by drying to constant weight at 105°. The titrations 
were performed at 25° at an ionic strength of 0.1 (KC1) as de­
scribed earlier (7, 13).
All reagents were analytical grade.
Treatment of Titration Data—-The titration results are pre- 
sented as normal titration curves (pH versus Z H), differential 
titration curves ( —d p E /d Z H versus Zh) or difference titration 
curves (AZH versus pH ), in which Z r, is the mean proton charge 
of the protein with the isoionic point (ZB =  0) as reference, 
dpH /dZ ,j the reciprocal of the buffer capacity and AZH the dif­
ference in protons bound by two proteins at the same pH. The 
analysis of differential titration curves has been given by  D e  
Bruin and Van Os (13) and we will give here the main features 
without going into details.
In the analysis it is assumed that the Linderström-Lang equa­
tion m ay be used to describe the titration behavior of each class 
of groups i.
pH =  pK,- +  log («,•/1 — a i )  —  0.868 wZ (1)
where K i  is the intrinsic dissociation constant of the w» groups 
of Class i, a i  its degree of dissociation, w  the electrostatic inter- 
action factor, and Z  the protein charge (see also Reference 14). 
If only protons are bound, then Z  =  Z H. The value of ZH is 
given by
Z  H =  ^ m t n  ^  '  Tli&i ( 2 )
where Zmax is the maximum positive charge of the native pro­
tein, so
2max =  ïïHiü +  ^a-NHï +  ^Lys +  ^Arg (3)
in which wH;8, n a_Ni , 2, n Lys, and nArg represent the number of 
titratable histidines, a-am ino groups, lysines, and arginines. 
Equations 1 and 2 describe the normal titration curve of a pro­
tein. From these equations the following expression can be 
derived.
- d  p ll /d Z ,, =  1/[2.303 £  nia i( l  -  «»)] +  0.868 w (4)
The inflection points in a normal titration curve of a protein, 
terminating the neutral region at the acid and alkaline side, are 
found in a differential titration curve as peaks. The positions 
of these peaks are indicated by Z T and Z n . In the case of hemo­
globin the second peak at Z n  is found near pH 9 and is always 
a sharp one. Calculations have shown that for Z lr  the following 
relation holds.
Z ll  =  Zma,x — TICOOH — nH's — na-NH2 (5)
in which wCOOH is the number of titratable carboxyl groups. 
W ith the help of Equation 3 this relation can be written as
Z n  =  « L y s  +  « A r g —  w c o o h  ( 6 )
The first peak at Z ,  (near pH 6) represents the titration end 
point of the carboxyl groups, at least when the peak is sharp. 
So for Z i  we have in first approximation the equation
Z i =  Zm«  — «cooh (7)
Combining the Equations 6 and 7 we have
Z l  —  Z j i  =  7lHi. +  (8)
Calculations have shown that Equation 7 m ay be applied to a 
good approximation when the first peak is well resolved. In  
that case the number of carboxyl groups is m ostly found only  
one group too large. As a consequence the number of histidines 
and a-amino groups, obtained with the help of Equation 8, is 
found one group too small. This implies that to the number of 
titratable histidines estimated in this way about one group has 
to be added. B y  means of calculated curves the result can be 
checked. Therefore, in view of the fact that the first peak in 
the differential titration curve of deoxyhemoglobin is much 
better resolved than in oxyhemoglobin, we have studied the 
deoxy form of the several hemoglobins to find the number of 
titratable histidines.
In deoxyhemoglobin the acid Bohr groups are mainly titrated  
at the acid side of the first peak. In our calculations we have 
assumed that there are four acid Bohr groups and, moreover, 
that they are carboxyl groups (15).
From the experimental differential titration curves Z t  and 
Z Ir can be read off w ith an accuracy of about 0.1.
All data and discussions are based on hemoglobin as a tetra- 
mer.
EESULTS
Human Hemoglobin A-i— This minor component of normal adult 
hemoglobin has two a  chains identical w ith those of human 
hemoglobin A. The other chains of hemoglobin A2 are dif­
ferent from the /3 chains and are called 5 chains. These 5 
chains have alanine B4(22)5, arginine G18(116)5, and asparagine 
G19(117)5, whereas in the /3 chains at the same positions, glu- 
tam ic acid B4(22)/S, histidine G18(116)/ï, and histidine G19- 
(117)/3 are found (Reference 16 and Table I). Besides these 
three polar replacements there are seven other differences be­
tween the (3 and 5 chains involving only nonpolar residues (18).
In Fig. 1 the differential titration curve of human hemoglobin 
A2 is given. Z n  for hemoglobin A2 is —6.0 while it is —10.0 
for hemoglobin A  (Table I I ) . This difference corresponds with  
the fact that hemoglobin A2 has two carboxyl groups less and 
two arginines more per tetramer than hemoglobin A  (see Equa­
tion 6). Z j is 15.0 so Z T — Z n  is 21.0 as compared with 23.0
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T a b l e  I
Partial amino acid composition of human and 
horse hemoglobin»
The numbers given for horse hemoglobin refer to the slow com­
ponent. In the fast component 1 lysine residue has been replaced 
by a glutamine (16). D ata from Dayhoff (17).
Nature of groups
Human Horse
cc P 7 s a 0
a-COOH..................... 1 1 1 1 1 1
A sn..................................... 4 6 5 8 4
14A sp..................................... 8 7 8 7 9
G in .................................... 1 3 4 5 1
1  1 4G lu ...................................... 4 8 8 7 3
Heme-COOH.................... 2 2 2 2 2 2
H is....................................... 10 9 7 7 10 9
a -N H i.................................. 1 1 1 1 1 1
L y s ...................................... 11 11 12 11 11 11
T yr....................................... 3 3 2 3 3 3
Cys. . . .................. 1 2 1 2 1 1
A rg........................ 3 3 3 4 3 4
20 15 10 5 0 -5 -10 ZH
F i g . 1. Differential titration curves of human deoxyhemo- 
globin Aa (O ) and F (© ).
for the A component. This means that in hemoglobin A2 two 
histidines less are titratable than in hemoglobin A.
Human Hemoglobin F—-This hemoglobin contains two a  
chains identical w ith those of hemoglobin A and two y  chains 
which differ from the /3 chains on 37 positions (18). Among 
these differences are histidines G18(116)/3 and H21(143)/S which 
are replaced by isoleucine and serine, respectively, in the y  
chains. From Table I we find nLys +  nAls =  58 and nCOoH =  
68; therefore we expect Z n  =  —10, as is found experimentally 
(see Fig. 1). Z j is 11.6, so Zr — Z n  is 21.6 as compared with
23.0 for hemoglobin A. Correcting for the fact that the sample 
studied consisted of 75% hemoglobin F  and 25% hemoglobin A 
we find Z i — Z n  =  21.1 and so we conclude that in hemoglobin  
F  two histidines less are titratable than in hemoglobin A. The 
equal number of titratable histidines in hemoglobins A2 and F
T a b l e  II
Survey of some of results obtained from differential titration curves 
of several deoxyhemoglobins and comparison with amino 
acid composition
Number of histidines
Hemoglobin 2/ Z n Z l  -  
Z n  — 
4“
Titrat­
able6
From
amino
acid
compo­
sition6
«Lys +  
»Argc
MOOüs
Human A 8............. 13.0 -1 0 .0 19.0 20' 38 56 66»
Human A2............. 15.0 - 6 . 0 17.0 18 34 58 64»
Human F A............ 11.6 -1 0 .0 17.6 18 34 58 68"
Horse................ 11.6 -1 3 .0 20.6 22' 38 57 70
Bovine A i .............. 11.3 -1 0 .3 17.6 18' 32 62 72
Bovine B ............... 9.5 -1 4 .0 19.5 20 34 58 72
a  Chain6................
|3 Chain*................
6.0 - 2 . 0
- 4 .7
7
6
10
9
14
14
16 >' 
191
0 Approximated number of titratable histidines obtained by 
using Equation 8, subtracting four a-amino groups.
h Obtained by rounding off upward to the next even integer 
the numbers in the preceding column.
0 D ata from Dayhoff (17) .
d Calculated w ith Equation 6 and rounded ofï to the next even 
integer.
‘ From Reference 7.
1 Checked by comparing with calculated curves.
0 In accord w ith amino acid composition.
h The hemoglobin studied contained 75% hemoglobin F  and 
26% hemoglobin A.
•' From Reference 6.
’ Taking into account one extra carboxyl group from the p- 
mercuribenzoate.
is also shown by the nearly identical shape of the two curves. 
The main difference is the expected shift of four groups.
Horse Hemoglobin—-Horse hemoglobin consists of two com- 
ponents roughly in equal amounts. They are called the slow 
and fast components according to their electrophoretic behavior 
(19, 20). In  Table I the amino acid composition of the slow 
and fast components is given. In the fast component lysine 
E 9(60)a  has been replaced by a glutamine residue (16). Crys- 
tallographically the two components are indistinguishable (9).
The differential titration curves of the two components are 
shown in Fig. 2. T he curves are nearly identical in shape and 
shifted about two groups w ith respect to each other; Z TI is —12.4 
for the slow and —14.6 for the fast component, so the shift is 
2.2. This means that, as expected, the two components have 
the same number of titratable histidines. The differential 
titration curve reveals in addition information about the total 
number of titratable carboxyl groups. Applying Equation 6 
with the data of Table I  we find w C o o h  = 70.4 for the slow and 
70.6 for the fast component. Rounding off these numbers to  
the next even integer we obtain a value of 70 titratable car­
boxyl groups in  both components.
The isoionic points of the cyanomet derivatives of the slow  
and fast components are about 7.2 and 7.0, respectively. This 
difference of 0.2 is what has to be expected because at Z H = 0  
—dpH /dZ n  is near 0.1 and the difference in charge between the 
two components is 2.
From the results described it can be concluded that for a de-
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dpH
F i g . 2. Differential titration curves of the two components 
of horse hemoglobin. Curve A , slow component. Curve B, 
a st component. The hemoglobins were titrated in the cyanomet 
form.
F ig . 3. Normal and differential titration curves of horse 
deoxyhemoglobin (@) and oxyhemoglobin (O)- Drawn lines 
have been calculated with the parameters of Table III.
T a b l e  III
Parameters used to calculate the normal and differential 
titration curve of horse hemoglobin
Number
of
groups
pK in 
deoxy­
hemo­
globin
pK in 
oxyhemo­
globin
Function Identity
66 4.25 4.25 Carboxyl groups
4 5.25» 5.85“ Acid Bohr groups Carboxyl groups
4 00 O » 6 .65“ Normal Bohr
14
2
7.1 7.1 groups Histidines and a-
2 7.8 7.8 amino groups
4 8.0 8.0
55 10.7 10.7 Lys, Tyr, Cys
■Zma* =  82.7 0.868w =  0.018
a From Reference 15.
termination of the number of titratable imidazole groups in 
horse hemoglobin it is permitted to use the naturally occurring 
mixture of the two components.
The normal and differential titration curve of the deoxygen- 
ated and oxygenated form of this mixture are shown in Fig. 3. 
W hen both components occur in equal amounts the calculated 
value for Z IIt based on Equation 6, w ith « c o o h  =  70, is —13.0 
as is found experimentally. The distance between the two 
peaks in the curve of the deoxy form is 24.6; subtracting from 
this number the four titratable a-am ino groups we obtain in 
first approximation 21 titratable histidines. Calculations showed 
that a good fit could only be obtained with 22 titratable 
histidines. This means that out of 38 histidines present, 16 
are masked. The observed shift to the left of Z t upon oxygena- 
tion and the increase of the peak at Z JT is due to the change in 
pK  of the acid and normal Bohr groups and resembles the sit- 
uation in bovine and human hemoglobin (6, 7). Table III 
gives the parameters which were used to obtain the calculated 
curves of Fig. 3. The table shows, besides the total number and 
pK  value of each class, the nature and presumed identity of the 
groups titrated. The lysines, tyrosines, and cysteines were 
considered as one class. From the 12 tyrosines present 8 were 
assumed to be titratable (21); the four cysteines and all lysines 
were considered as being titratable. The number of lysines is 
the mean value of the number of lysines occurring in the two 
components.
Bovine Hemoglobin B— Two kinds of bovine hemoglobin called 
A  and B are known (19, 22). In  a previous report we studied 
the titration behavior of bovine hemoglobin A (6). This mol­
ecule difïers only at three sites from hemoglobin B : the residues 
glycine-15, lysine-18, and lysine-119 in the 8  chain of hemoglo­
bin A  are replaced by serine, histidine, and asparagine in hemo­
globin B (17). Fig. 4 shows the differential titration curves of 
the deoxy form of both hemoglobins. T he second peak is 
found at —14.0 for the B  component, while in hemoglobin A 
Z u  is —10.3. This difïerence arises from the different number 
of lysines (see Equation 6 and Table II). For hemoglobin A  
we found Z j — Z u  =  23.5 while for hemoglobin B this value is 
21.6. This result clearly indicates that the two extra histidines 
in hemoglobin B  are titratable.
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F ig . 4. Differential titration eurves of bovine deoxyhemo- 
globin A (O ) and B (© ).
P i g . 5. Difference titration curve of bovine hemoglobins A 
and B. ( • )  D eoxy form; (O ) oxy form.
Fig. 5 gives the difference titration curve of the A and B type  
both for the deoxy and the oxy form. Assuming that the pK  
values of all common titratable residues in both forms are the 
same, this curve represents the titration of the extra histidines 
in  hemoglobin B . From this curve au apparent pK  of about 
7.8 can be estimated for this histidine in both the deoxygenated  
and oxygenated state. W e further wish to remark that both  
hemoglobins A  and B  should contain 72 titratable carboxyl 
groups, in contrast w ith the amino acid analysis which gives a 
number of 76 (17).
DISCTJSSION
Bovine Hemoglobin B— T he fairly high pK  of 7.8 for histidine 
Bl(18)/3 in bovine hemoglobin B  strongly suggests that this 
residue shows some interactions w ith other groups. These 
groups could be the carboxyl groups of aspartic acid B3(20)/3 
and glutamic acid B4(21)/3 (see Fig. 3 of Reference 23). Study- 
ing the atomic model of horse hemoglobin and assuming struc- 
tural correspondence w ith bovine hemoglobin it is even possible 
to  bring both carboxyl groups within saltbridge distance to
histidine B l .1 The observation that the pK  has the same value 
in both deoxy- and oxyhemoglobin can be understood in view of 
the fact that the three residues are found nearly in sequence in 
the peptide chain and are not located a t interfaces so that they  
probably are little sensitive to the structural changes which take 
place upon oxygenation of deoxyhemoglobin. Assuming that 
the pK  of a normal histidine is near 7 it can easily be calculated 
that a pK  shift to 7.8 is associated w ith a Standard free energy 
change of about 1 kcal per mole which is a reasonable value for 
the formation of a saltbridge (24).
Amides in Horse Chain—Table I  shows that the a  chain of 
horse hemoglobin contains 15 titratable carboxyl groups in both 
components; in view of our titration results this means that 
there are 20 titratable carboxyl groups per /S chain, which num­
ber includes the terminal COOH and the two heme carboxyl 
groups. Therefore we may conclude that out of a total number 
of 28 asparagine and glutamine residues per chain, 17 are 
present as aspartic and glutamic acids and the remaining 11 as 
amides. Smith and Chung (25) have located nine amides in the 
residues 1 to 82 and 117 to 146 of the horse /? chain. These 
nine amides are found at the same sites both in the human and 
in the horse /3 chains. Therefore according to our titration  
results the Region 83 to 116 should contain the two remaining 
amides. Because the human /3 chain has asparagine at posi- 
tions 102 and 108 (17), it  is very likely that the two additional 
amides in the horse 18 chains will also be found at the positions 
102 and 108.
Masked Imidazole Oroups in Horse Hemoglobin— The number 
of 16 masked imidazole groups we found in horse hemoglobin is 
four larger than reported b y  Geddes and Steinhardt (3) and 
Tanford and Nozaki (4) who found 12 masked groups. The 
experimental approach of Geddes and Steinhardt was quite 
different from ours and this could be an explanation for the dif­
ference in outcome. Tanford and Nozaki, however, also fol- 
lowed a procedure in which they measure the number of titrata­
ble histidines, so a better correspondence with our reported value 
could be expected. In view of the fact that the number of ti­
tratable histidines calculated from the titration data in their 
way of analysis is greatly influenced by  the number of titratable 
carboxyl groups, the observed discrepancy can be explained as 
probably caused by the fact that they assumed a number of 78 
titratable carboxyl groups while our results indicate a number 
of 70. M oreover the value of 9.1 they assumed for pK BH seems 
to be too low (26) and has influenced their results too. In their 
analysis of the titration data of human hemoglobin A Bucci et 
al. (5) and Tanford and Nozaki (4) reported a number of 16 
masked imidazole groups, only two less than we found (7). 
This better agreement is probably due to  the fact thay they use 
for hemoglobin A the proper number of ionizable carboxyl groups.
I t  is further noteworthy to mention here that Geddes and 
Steinhardt (3) suppose that at acid pH, besides imidazole groups, 
also other groups such as neutral «-amino or ionized phenoxy 
groups, are getting unmasked. However, an objection to this 
supposition could be made. In the case of human hemoglobin 
A we found that Equation 6 could be applied. If neutral e- 
amino groups exist at the pH  of the second peak (pH about 9)
1 Dr. M. F. Perutz informed us that histidine Bl(18)/S is more 
likely to interact with aspartic acid B3(20),ö rather than with  
glutamic acid B4(21)/3.
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T a b l e  IV
Position of histidine residues in  chains of human, horse, 
and bovine hemoglobins“
H denotes that a histidyl residue is found at that position.
Position in 
polypeptide 
chain
Human
horse
bovine
Human Horse Bovine Remarks 
concerning 
non-a chains
a 0 T 6 0 0
NA2................ H H H t; external
B I ........................... H H «
CD3................ H
D 6..................... H
E7..................... H H H H H H t; distal h isti­
dine
E13.................... H t; external
E20.................... H t; external
E F 1.................. H H H H H H
F 8 ... . H H H H H H n; proximal his­
tidine
FG1................... H
FG4................... H H H H H
G10.................... H
G 1 8 ......................... TT n
G 1 9 . ...................... H H H H
H 5..................... H
H 2 1 ......................... TT TT H TT t; external
HC3.................. H H H H H t; Bohr group
“ From References 17, 27, and 28.
6 1 =  titratable; n =  nontitratable. For details see text. 
c Only in bovine hemoglobin B.
n Lys would be smaller and so Z u  would have a value different 
from that we found experimentally. The same is true if ionized 
phenoxy groups are masked. In that case Equation 6 must be 
extended with a term representing the number of ionized phe­
noxy groups and that would also result in a shift of Z r i . I t  
seems more likely to us that the extra masked groups are ionized 
carboxyl groups being partners in saltbridges which are broken 
up by the acid denaturation.
M asked Imidazole Groups in  Human Hemoglobins— From the 
differential titration curve of hemoglobins A and A2 we con- 
cluded that of the four histidines which the A component has in 
excess only two are titratable. Because the a  chains in hemo­
globins A and A2 are identical it can be expected that these 
chains show the same number of titratable histidines. I t  is 
further reasonable to assume th at histidines which are found at 
the same structural places in the non-a chains also will show the  
same titration behavior. Based on these assumptions we are 
led to the conclusion that either histidine G18 or histidine G19 is 
not titratable in the /3 chains (Table IV ). W hen the titration 
results of hemoglobins A and F  are compared in the same way 
the conclusion can be drawn that either histidine G18 or histi­
dine H21 will be not titratable. Combining these two observa- 
tions the conclusion can be reached that in the human /3 chain 
histidine G18 is masked and both histidines G19 and H21 are 
titratable. I t  should be stressed in this respect that for these 
conclusions the identity of the acid Bohr groups is not relevant; 
only when the exact number of titratable histidines of a particu- 
lar hemoglobin is the object of the titration analysis this identity  
is of importance. The titratability of histidine G19 is consist­
ent w ith the difiference in electrophoretic m obility between 
hemoglobins A and P  (29). In the latter abnormal hemoglobin 
histidine G19 is substituted by an arginine. The experiments 
reported showed that at pH  8.5 hemoglobin P shows a smaller 
anodic m obility than hemoglobin A, while the m obility is equal 
at pH  6 . This behavior can only be understood if titratability  
of histidine G19 is assumed. The titratability of histidine H21 
is supported by the fact that this histidine is very probably in- 
volved in the binding of 2 , 3-diphosphoglycerate by  deoxyhemo- 
globin A (24). M oreover histidine H21 is external and there- 
fore probably titratable (30). The question remains which 
other particular histidine residues in the human /3 chain are ti­
tratable or not titratable. We have shown that most probably 
G19 and H21 are titratable and that G18 is not titratable. From  
electrophoretic studies on hemoglobin Zürich it can be concluded 
that histidine E7 is titratable (31). The titratability of histidine 
HC3 is w ithout doubt because of its involvem ent in the alkaline 
Bohr effect (24, 32). The proximal histidine F 8 is m ost likely  
not titratable while histidine NA2, which is the 2nd residue in 
the |8 chain with its imidazole groups external (23), is likely to  
be titratable. The titratability of histidines EF1 and FG4  
orobably might be elucidated from a study of hemoglobin J 
Iran, which has aspartic acid at EF1 (33) and of hemoglobin  
Ma,lmö, which ha.s glutamine at FG4 (34).
According to our previously reported experiments both the a  
and /3 chains have three nontitratable histidines (7). I t  is 
nearly w ithout doubt that these residues are also not titratable 
in the «2182 tetramer. On the other hand titratable residues in 
the tetramer are expected to be titratable in the isolated chains 
too. Therefore from the data of Table II it  can easily be cal- 
culated that the formation of the a.$-i tetramer from two isolated  
a  and 0  chains leads to the masking of six imidazole groups. In  
view of the findings and assumptions mentioned above, this 
means that upon assembling the a-fii tetramer either two or 
three of the titratable histidines in the isolated a  chains become 
nontitratable; the exact number depends on whether one or no 
histidine becomes masked in the (3 chains. The question as to  
which particular residues in the a  chains are titratable or not 
titratable and which residues might become masked in the te t­
ramer is more difficult to answer than in the case of the (3 chains 
because the kind of information described above for the 0  chains 
is lacking for the a  chains. The estim ation of the number of 
histidines which are masked upon formation of the tetramer 
critically depends on the correctness of the figures used. The 
determination of the number of titratable histidines in the free 
jü chains is fairly complicated (7). Moreover the absolute num ­
ber of titratable histidines in hemoglobin depends on the assump- 
tion about the nature of the acid Bohr groups. W e have as­
sumed, as already mentioned, that they are carboxyl groups, 
but if these groups are histidyl residues only one group in the a  
or j3 chains becomes masked in the tetramer. From studies of 
the atomic model of hemoglobin it is as yet impossible to  see 
where all the nontitratable residues in the isolated chains might 
be found, let alone to locate the six histidines which m ight be­
come masked upon formation of the tetramer.
As mentioned in the previous section, Tanford and Nozaki 
(4) and Bucci et al. (5) have reported that most probably 22 
imidazole groups are titratable in human hemoglobin. M ore­
over Bucci et al. reported that 7 histidine residues are titratable  
in the 0  chains. W ith these values we arrive at the same con­
clusions concerning the number of imidazole groups which be-
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come masked upon formation of the tetramer as with our 
values.
Comparison of Human, Horse, and Bovine Hemoglobins—-For 
the comparison of the human hemoglobins with horse and bovine 
hemoglobin we will start from the same basic assumption that 
residues at structurally identical positions will show similar ti­
tration behavior; in addition we will use the knowledge about 
the titratability of special groups obtained by  comparing the 
several human hemoglobins w ith each other. Because the ce 
chains of the hemoglobins studied are all alike as far as the posi­
tions of histidines are concemed, the difference in titration be­
havior of the hemoglobins should be found in the j3 chains. For 
this reason the difference in titratable histidine content of two 
groups between horse and human hemoglobins A can only be 
understood if histidines E13 and E20 are titratable; this inter- 
pretation is supported by  the fact that both residues are external 
(35). A  similar comparison between human hemoglobin A and 
bovine hemoglobin A failed to give th e right answer; based on 
the data of Table IV human hemoglobin is expected to have four 
titratable histidines in excess, while actually only two are found. 
As yet we have no explanation for this. One m ay wonder, how- 
ever, whether it  is justified to compare hemoglobins of different 
mammals in the way we did, because they show besides dif­
ferences in histidine content m any other amino acid replace- 
ments which might introducé some structural differences. This 
could make our basic assumption less valid. Although some 
doubt is justified in this respect we do not think th at this qual- 
ification is needed when hemoglobins of the same mammal are 
compared because the amino acid replacements in these cases 
are not very numerous, which makes structural correspondence 
more likely.
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